1Abe M, Goto T, osaka MK, et al. Differences in kappa to lambda(κ:λ)ratios of serum and urinary free light chains[J]. Clin Exp Immunol,1998,111:457-462.
2Imoto M, Ishikawa K, Yamamoto K, et al. A Case of multiple myeloma IgG(λ) type with low molecular weight κ light chain[J].Clin Chim Act, 1998,277: 99-105.
5Morie AG, Martha QL, John A, et al. Phase Ⅱ trail of high-dose dexamethasone for previously treated immunoglobulin light-chain amyloidosis[J]. Am J Hematol, 1999,61:115-119.
6Levinson SS. Kappa/lambda index for confirming urinary free light chain in amyloidosis AL and other plasma cell dyscrasias[J]. Clin Chem, 1991,37(6): 1122-1126.
7Kathleen JW, Gerald G, Guillermo AH, et al. Cardiac amyloidoma with IgM-κ gammopathy[J]. Arch Pathol Lab Med, 1994,118:1148-1150.
8Stevenson FK, Speelerberg M and Smith JL. Monoclonal immunoglobin light chain in urine of patients with B lymphocytic disease:its source and use as a diagnostic aid[J].Br J Cancer, 1983,47:607-612.
9Borgonovo G,R. d'Oiron, Amato A, et al. Primary lymphoplasmacytic lymphoma of the liver associated with a serum monoclonal peak of IgG κ[J]. Am J Gastroenterol,1995,90:137-140.
10Solling K,Solling J and Romer FK. Free light chains of immunoglobulins in serum from patients with rheumatoid arthritis, sarcoidosis, chronic infections and pulmonary cancer[J]. Acta Med Scand, 1981,209:473-477.
